article thumbnail

Board Governance Excellence: The Pinnacle of Organizational Success

N2Growth Blog

Moreover, governance excellence is synonymous with nurturing a culture of transparency, trust, and ethical behavior. Such a board is not merely a governance powerhouse but a catalyst for innovation, decision-making sagacity, and long-term sustainability.

article thumbnail

Feelings Of Professionalism Can Result In Unethical Behavior

The Horizons Tracker

The researchers provide a two-stage model to help organizations and individuals safeguard against any possible conflicts of interest. When we have a high sense of professionalism, however, we can often be blinded to such conflicts of interest. The second part is to neutralize the influence after accepting any gifts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Harvard Business Review

Legitimate concerns over conflict of interest that have resulted in overly extreme preventative policies are a central cause. It is time for all parties to revisit those policies and replace them with rules that recognize both true conflicts and true confluences of interest. Insight Center. Sponsored by Optum.

article thumbnail

William Miller on Business Model Innovation

Rajesh Setty

I have known Dr. William Miller (co-founder of Value Centered Innovation ) for a number of years and every conversation with him on business model innovation and beyond has been delightful and insightful. RS: What are the larger considerations to defining and innovating a business model?

article thumbnail

The Case for Corporate Disobedience

Harvard Business Review

But as Steve Blank, Henry Chesbrough, and others have pointed out , that advantage is offset by the daunting fact that corporate innovators have to fight a war on two fronts. This is where the concept of stealth innovation can help you. To some extent, you can secure the necessary flexibility by negotiating it up front.

article thumbnail

Big Pharma's Hidden Business Model and How Your Company Funds It

Harvard Business Review

Equating "innovative" with new molecules misses the point: to develop clinically superior new medicines. The apparent business model of Big Pharma emphasizes the billions spent at great risk to find "innovative" and "breakthrough" new molecules that must be priced high to recover research costs that have become "unsustainable."

article thumbnail

How Pharma Can Fix Its Reputation and Its Business at the Same Time

Harvard Business Review

By that I mean that pharma companies should develop innovative treatments for pervasive unmet medical needs; avoid corruption, collusion, and other unethical marketing practices; and make sure that their products reach as many patients around the world as possible. Enhance corporate reputations.